The combination of a targeted pegylation site and an appropriately-sized PEG molecule help enhance the potential of interferon therapy in the treatment of hepatitis C.
Click the links below to see: 1) The benefits of pegylation; and 2) the role that PEG molecule size plays in the ability to penetrate tissue and organs outside the liver, where hepatitis C may also reside.
Now Playing: Biodistribution
| Video Segments: | |
|---|---|
| Pegylation (1min / 25sec) | |
Now Playing |
Biodistribution (30sec) |
The clinical relevance of these mechanism-of-action data have not been established.
Please see the PEG-INTRON® Prescribing Information.
For more information on why PEG-INTRON® is the treatment choice for many hepatitis C patients, read Why Prescribe PEG-INTRON®?
